Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2010
03/31/2010EP2168947A1 Novel compound having secretase inhibitory activity
03/31/2010EP2168946A1 Crystalline form of modafinil, and methods of preparing the crystalline form
03/31/2010EP2168944A1 Amine compound and pharmaceutical use thereof
03/31/2010EP2168600A1 Therapeutic or prophylactic agent for cerebral aneurysm
03/31/2010EP2168598A1 Method of Treatment Using Ligand-Immunogen Conjugates
03/31/2010EP2168586A1 Active ingredient of a medicinal agent, a medicinal agent, a pharmaceutical composition and method for treating dementia syndrome patients
03/31/2010EP2168585A1 Pharmaceuticals compositions of a neuroactive steroid and uses thereof
03/31/2010EP2168584A1 Pharmaceutical composition comprising the combination of a triazolobenzodiazepine and a selective serotonin reuptake inhibitor
03/31/2010EP2168583A1 Use of substituted 2,3-dihydroimidazo[1,2-c]quinazolines for the treatment of myeloma
03/31/2010EP2168582A1 Combinations of substituted 2,3-dihydroimidazo[1,2-c]quinazolines
03/31/2010EP2168581A2 Stable polymorph of N-(3-ethynylphenylamino)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine hydrochloride, methods of production, and pharmaceutical uses thereof
03/31/2010EP2168580A1 Remedy or preventive for integration dysfunction syndrome
03/31/2010EP2168579A1 Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation
03/31/2010EP2168578A2 2-Amido-Thiazole-Based Compounds Exhibiting ATP-Utilizing Enzyme Inhibitory Activity, and Compositions, and Uses Thereof
03/31/2010EP2168577A1 Drug having effect of promoting hepatocyte growth
03/31/2010EP2168576A2 New utilities of tricyclic compounds
03/31/2010EP2168575A1 Medicinal agent for treating patients suffering from diseases caused by the monoaminooxidase excessive activity and a method for treating patients suffering from diseases caused by the monoaminooxidase excessive activity
03/31/2010EP2168574A1 Compound for local deletion of tumors
03/31/2010EP2168573A1 Formulations comprising ezetimibe
03/31/2010EP2168440A1 Equol-containing extract, method for production thereof, method for extraction of equol, and equol-containing food
03/31/2010EP2167684A2 Targeting of sall4 for the treatment and diagnosis of proliferative disorders associated with myelodysplastic syndrome (mds)
03/31/2010EP2167681A1 Treatment of cardiovascular disease with salicylates
03/31/2010EP2167674A1 Nutritional compositions
03/31/2010EP2167662A2 Pharmaceutical compounds comprising abasic oligonucleotides
03/31/2010EP2167661A2 Rnai mediated knockdown of numa for cancer therapy
03/31/2010EP2167549A2 Materials comprising water-soluble polymer particles and methods of making and using them
03/31/2010EP2167522A2 Triazole-based aminoglycoside-peptide conjugates and methods of use
03/31/2010EP2167510A1 Sirtuin modulating imidazothiazole compounds
03/31/2010EP2167509A1 Piperazine and ý1,4¨diazepan derivatives as nk antagonists
03/31/2010EP2167508A1 Compounds for treating duchenne muscular dystrophy
03/31/2010EP2167507A1 Cysteine protease inhibitors
03/31/2010EP2167506A2 Method for producing n-methylnaltrexone bromide
03/31/2010EP2167504A2 Thiadiazole modulators of pkb
03/31/2010EP2167501A1 Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators - 841
03/31/2010EP2167500A1 Aminoacyl prodrugs as an active pharmaceutical ingredient for thromboembolic disorders
03/31/2010EP2167499A2 Substituted oxazolidinones and use thereof
03/31/2010EP2167498A1 Compounds and compositions as itpkb inhibitors
03/31/2010EP2167497A2 Heterocyclic compounds useful as raf kinase inhibitors
03/31/2010EP2167495A1 Substituted oxazolidinones and the use thereof
03/31/2010EP2167494A1 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
03/31/2010EP2167493A1 Salts of 3- (1h-ind0l-3-yl) -4- [2- (4-methyl-piperazin-i-yl) -quinazolin-4-yl]-pyrrole-2,5-di one
03/31/2010EP2167492A2 Novel amide derivative for inhibiting the growth of cancer cells
03/31/2010EP2167490A1 Triazole derivatives having antifungal activity, method for the preparation thereof, and pharmaceutical composition comprising the same
03/31/2010EP2167485A2 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
03/31/2010EP2167482A1 Substituted bicyclic heteroaryl compounds for the treatment of cardiovascular diseases
03/31/2010EP2167476A2 Novel hiv reverse transcriptase inhibitors
03/31/2010EP2167474A1 Urocanic acid derivatives useful for the treatment of immune-related and inflammatory diseases
03/31/2010EP2167472A2 1-benzylpyrazole derivatives, preparation thereof and therapeutic use thereof
03/31/2010EP2167471A1 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use
03/31/2010EP2167470A1 Triazolo [1, 5-a]quinolines as adenosine a3 receptor ligands
03/31/2010EP2167469A1 Sulfonyl-quinoline derivatives
03/31/2010EP2167468A2 Process for the preparation and pharmaceutical formulations for 4-quinolinones and quinolines and use thereof
03/31/2010EP2167466A1 N-phenyl hydrazides as modulators of the ghrelin receptor
03/31/2010EP2167465A1 Indolinone derivatives and their use in treating disease-states such as cancer
03/31/2010EP2167460A2 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same
03/31/2010EP2167459A1 Novel triazine compounds for treatment of cancer
03/31/2010EP2167457A2 Novel naphthalene derivatives, process for the preparation thereof and pharmaceutical compositions containing same
03/31/2010EP2167196A1 Heterocyclic compounds for the treatment of tuberculosis
03/31/2010EP2167195A1 Vaginal odorants
03/31/2010EP2167165A2 Device and method for restoration of the condition of blood
03/31/2010EP2167132A1 Resuscitation fluid
03/31/2010EP2167105A1 Antimicrobial film-forming composition, antimicrobial film, and method of verifying the presence of an antimicrobial film
03/31/2010EP2167104A1 Bifunctional synthetic molecules
03/31/2010EP2167103A1 Self-assembling amphiphilic polymers as anticancer agents
03/31/2010EP2167102A2 Use of hyaluronic acid for preparing compositions particularly for improving the function of skin, eye and mucous membrane protection
03/31/2010EP2167101A2 Antibodies and sirna against growth hormone, prolactin and proliferin for use in the treatment of tumors and endometriosis
03/31/2010EP2167100A2 The redox/fyn/c-cbl pathway
03/31/2010EP2167099A2 Treatment of pulmonary hypertension with carbonic anhydrase inhibitors in combination with a sympathomimetic amine
03/31/2010EP2167098A1 Allopregnanolone in a method for enhancing neurological function (alzheimer disease)
03/31/2010EP2167097A2 Metal complexes incorporated within biodegradable nanoparticles and their use
03/31/2010EP2167095A2 Compounds for treatment
03/31/2010EP2167093A1 Pharmaceutical compositions for the treatment of chronic heart failure comprising pyrazolopyrimidinone derivative compound
03/31/2010EP2167092A2 Quinazoline derivatives as pi3 kinase inhibitors
03/31/2010EP2167091A1 Cinnoline compounds for use in the treatment of schizophrenia
03/31/2010EP2167089A1 Therapeutic compositions and the use thereof
03/31/2010EP2167088A1 Therapeutic compositions and the use thereof
03/31/2010EP2167085A1 4- [2- (4-methylphenylsulfanyl) phenyl]piperidine for the treatment of irritable bowel syndrome (ibs)
03/31/2010EP2167083A2 Novel 1- heteroaryl-3-azabicycloý3.1.0¨hexanes, methods for their preparation and their use as medicaments
03/31/2010EP2167080A1 Pharmaceutical formulation comprising pramipexole
03/31/2010EP2167079A1 Steroid-sparing methods of treating brain edema
03/31/2010EP2167078A2 Use of pactimibe for the preparation of a drug intended to prevent or treat a disease caused by a sebaceous gland dysfunction in humans or animals
03/31/2010EP2167075A1 Mixed lineage kinases and metabolic disorders
03/31/2010EP2167074A2 Antibiotic compounds
03/31/2010EP2167073A1 Terpenes with antifungal activity against malassezia yeasts
03/31/2010EP2167072A1 Use of oleocanthal for treatment of cutaneous inflammation
03/31/2010EP2167071A2 A baclofen solution for low-volume therapeutic delivery
03/31/2010EP2167070A1 Use of nitric oxide releasing compounds in the treatment of chronic pain
03/31/2010EP2167067A1 Use of eflucimibe for the production of a medicament for the prevention or treatment of a disease caused by sebaceous gland dysfunction in humans or animals
03/31/2010EP2167062A1 Compositions and uses comprising a retinoid compound, an anti-irritant compound and benzoyl peroxide in acne
03/31/2010EP2167059A2 Novel prolactin compounds
03/31/2010EP2167058A2 Family of pfkfb3 inhibitors with anti-neoplastic activities
03/31/2010EP2167057A1 Pde inhibitors for the treatment of hearing impairment
03/31/2010EP2167055A1 Transdermal tobacco alkaloid reservoir patch
03/31/2010EP2167050A1 Taste masked pharmaceutical compositions of s-alkylisothiouronium derivatives
03/31/2010EP2167049A1 Tamper resistant lipid-based oral dosage form for opioid agonists
03/31/2010EP2167046A2 Pharmaceutical solid preparation comprising benzazepines and production method thereof
03/31/2010EP2167044A1 Mucoadhesive vesicles for drug delivery
03/31/2010EP2167043A2 Nutraceutical co-crystal compositions
03/31/2010EP2167042A2 Pharmaceutical aerosol compositions comprising fluticasone
03/31/2010EP2167034A1 Film shreds and delivery systems incorporating same
1 ... 2326 2327 2328 2329 2330 2331 2332 2333 2334 2335 2336 2337 2338 2339 2340 2341 2342 2343 2344 2345 2346 ... 7860